In allergic rhinitis models, Rh1 administration significantly decreased IL-4-positive CD4+ T cells while increasing IFN-γ-positive CD4+ T cells in nasal-associated lymphoid tissue. This evidence concerns the gene IL4 and allergic rhinitis.